4//SEC Filing
Richman Michael 4
Accession 0001123292-20-000457
CIK 0001661059other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:35 PM ET
Size
5.2 KB
Accession
0001123292-20-000457
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Richman Michael
DirectorPresident & CEO
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-02-28+225,000→ 225,000 totalExercise: $41.76Exp: 2030-02-27→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on February 28, 2021. The remainder vests in 36 monthly installments beginning on March 28, 2021.
Documents
Issuer
NextCure, Inc.
CIK 0001661059
Entity typeother
Related Parties
1- filerCIK 0001366265
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:35 PM ET
- Size
- 5.2 KB